Alseres Pharmaceuticals, Inc. (ALSE)

USD 0.01

(100.0%)

Market Cap (In USD)

398.25 Thousand

Revenue (In USD)

473.73 Thousand

Net Income (In USD)

-941.52 Thousand

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.005-0.01
PE
-
EPS
-
Beta Value
0.215
ISIN
US0211522026
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Peter G. Savas
Employee Count
-
Website
https://www.alseres.com
Ipo Date
1994-12-22
Details
Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.